Infliximab/mesalazineDrug intolerance and lack of efficacy: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2023年 / 1964卷 / 1期

关键词：

D O I：

10.1007/s40278-023-42790-6

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：232 / 232

相关论文

共 50 条

[41] Infliximab/Methotrexate/TofacitinibInfusion reaction and lack of efficacy: case report
Reactions Weekly, 2024, 2024 (1) : 234 - 234
[42] Ciclosporin/Infliximab/UstekinumabAnaphylactic shock and lack of efficacy : case report
Reactions Weekly, 2024, 2020 (1) : 138 - 138
[43] Multiple drugsFatigue, drug intolerance and lack of efficacy: case report
Reactions Weekly, 2023, 1981 (1) : 260 - 260
[44] Adalimumab/infliximab/mesalazineTakayasu arteritis and lack of efficacy: case report
Reactions Weekly, 2023, 1945 (1) : 23 - 23
[45] Infliximab/unspecified steroidsInvasive aspergillosis and lack of efficacy: case report
Reactions Weekly, 2022, 1895 (1) : 222 - 222
[46] Azathioprine/infliximab/methylprednisoloneBronchoesophageal fistula and lack of efficacy: case report
Reactions Weekly, 2023, 1963 (1) : 114 - 114
[47] Infliximab/prednisoneDrug specific antibodies and lack of efficacy: case report
Reactions Weekly, 2021, 1836 (1) : 422 - 422
[48] Antineoplastics/immunotherapiesDrug intolerance, neuropathy and lack of efficacy: case report
Reactions Weekly, 2023, 1986 (1) : 60 - 60
[49] Penicillamine/trientine/zincDrug intolerance and lack of efficacy: case report
Reactions Weekly, 2024, 2037 (1) : 356 - 356
[50] Levetiracetam/levodopa/carbidopaDrug intolerance and lack of efficacy : case report
Reactions Weekly, 2024, 2019 (1) : 244 - 244

← 1 2 3 4 5 →